Insulet Corporation - Common Stock (NQ:PODD)

296.84 -7.65 (-2.51%)

Streaming Delayed Price Updated: 1:47 PM EST, Dec 8, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Assessing Insulet: Insights From 6 Financial Analysts ↗

September 08, 2025

Via Benzinga

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today ↗

September 03, 2025

Via Benzinga

2 Mid-Cap Stocks Worth Your Attention and 1 We Ignore

September 01, 2025

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

Via StockStory

3 Cash-Producing Stocks to Target This Week

August 29, 2025

Cash-generating companies often have the flexibility to invest, return capital to shareholders, or navigate downturns. The best of these businesses not only accumulate cash but deploy it strategically...

Via StockStory

Patient Monitoring Stocks Q2 Highlights: Insulet (NASDAQ:PODD)

August 25, 2025

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.

Via StockStory

Topics Artificial Intelligence

Is the Market Bullish or Bearish on Insulet? ↗

August 13, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Insulet Elevates Eric Benjamin to Chief Operating Officer

August 25, 2025

From Insulet Corporation

Via Business Wire

2 Surging Stocks with Exciting Potential and 1 We Brush Off

August 25, 2025

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage...

Via StockStory

2 Growth Stocks to Add to Your Roster and 1 Facing Headwinds

August 22, 2025

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Via StockStory

Demystifying Insulet: Insights From 7 Analyst Reviews ↗

August 21, 2025

Via Benzinga

Cisco, Rocket Companies, Insulet And More On CNBC's 'Final Trades' ↗

August 20, 2025

Lending support to his choice, BTIG analyst initiated coverage on Rocket Companies with a Buy rating and $25 price target. Cisco and Insulet also discussed.

Via Benzinga

Insulet to Participate in Upcoming Investor Conferences

August 19, 2025

From Insulet Corporation

Via Business Wire

Here's How Much You Would Have Made Owning Insulet Stock In The Last 15 Years ↗

August 18, 2025

Via Benzinga

2 Safe-and-Steady Stocks for Long-Term Investors and 1 We Brush Off

August 18, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

Insulet Corp (NASDAQ:PODD) Fits Minervini’s Trend Template with Strong Growth Momentum ↗

August 15, 2025

Insulet Corp (PODD) aligns with Minervini's high-growth momentum strategy, showing strong technical uptrends, robust earnings growth, and solid revenue expansion. A top pick for investors seeking...

Via Chartmill

PODD Q2 Deep Dive: Omnipod 5 Adoption and International Expansion Drive Results

August 12, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 32.9% year on year to $649.1 million. On top of that,...

Via StockStory

Topics World Trade

Boston Scientific Stock Hits A Record High, Consolidates. Prepping For Another Run? ↗

August 12, 2025

Boston Scientific stock rose to a record high in July and then consolidated. Prepping For a fresh run higher?

Via Investor's Business Daily

Topics ETFs

Stay informed with the top movers within the S&P500 index on Thursday. ↗

August 07, 2025

Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Insulet (NASDAQ:PODD) Beats Expectations in Strong Q2, Stock Soars

August 07, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 32.9% year on year to $649.1 million. On top of that, next quarter’s...

Via StockStory

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5 ↗

August 07, 2025

Insulet beats Q2 estimates with strong Omnipod growth and lifts 2025 revenue outlook on rising adoption and expanding global customer base.

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

August 07, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Applovin, Sunrun, Duolingo, Tutor Perini, Installed Building Products And Other Big Stocks Moving Higher On Thursday ↗

August 07, 2025

Via Benzinga

Thursday's session: gap up and gap down stock in the S&P500 index ↗

August 07, 2025

Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.

Via Chartmill

Insulet (PODD) Q2 Revenue Jumps 33% ↗

August 07, 2025

Via The Motley Fool

Insulet Pops As Diabetes Medtech Continues Its Streak Of 'Impressive Beat-And-Raises' ↗

August 07, 2025

The company is still in the early stages of adding patients with type 2 diabetes to its client base.

Via Investor's Business Daily

Insulet Corp. (NASDAQ:PODD) Delivers Strong Q2 2025 Earnings, Surpassing Revenue and EPS Forecasts ↗

August 07, 2025

Insulet Corp. (PODD) reported strong Q2 2025 earnings, beating revenue and EPS estimates with $649.1M in sales and $1.17 adjusted EPS. Stock rose 4.58% pre-market. Raised full-year guidance signals...

Via Chartmill

These S&P500 stocks are moving in today's pre-market session ↗

August 07, 2025

Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday?

Via Chartmill

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

August 07, 2025

From Insulet Corporation

Via Business Wire

Insulet (PODD) Q2 Earnings: What To Expect

August 05, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Thursday before the bell. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence Economy World Trade

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.